Abstract: This paper compared the anti-tumor effects of different components of selenium-enriched yeast (selenium-enriched yeast protein, glucan and mannan) by using Lewis lung carcinoma (LLC) tumor-bearing mice model, identified the best active component of selenium-enriched yeast against tumors, and clarified its anti-tumor mechanism. The results showed that the tumor growth of LLC tumor-bearing mice could be inhibited by selenium-enriched yeast protein, glucan and mannan, and their inhibition rates were 36.08%, 18.62% and 12.75%, respectively. The mRNA expression of B-cell lymphoma-2(Bcl-2), vascular endothelial growth factor(VEGF), CD34 and interleukin-10(IL-10) could be significantly decreased by selenium-enriched yeast protein, glucan and mannan, while the mRNA expression of Bax, Caspase-3 and tumor necrosis factor-α (TNF-α) could be significantly increased. Selenium-enriched yeast protein exhibited the strongest regulative effect on the expression of these mRNAs. It showed that selenium-enriched yeast protein, glucan and mannan could inhibit the tumor growth of LLC tumor-bearing mice by regulating tumor angiogenesis, immunity and apoptosis, among which selenium-enriched yeast protein exhibited the strongest anti-tumor effect and was the best active component of selenium-enriched yeast against tumors.
Keywords: selenium-enriched yeast; protein; glucan; mannan; anti-tumor effects